Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World Data
Conclusions
Our findings support the robustness, generalizability and clinical applicability of the END-PAC model.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Databases & Libraries | Diabetes | Endocrinology | Gastroenterology | Health Management | Israel Health | Pancreas | Pancreatic Cancer | Study